ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 581

Cell-Mediated Neutrophil Lysis-a Mechanism Promoting Hypercitrullination in Rheumatoid Arthritis?

Tal Gazitt1, Christian Lood1, Xizhang Sun2, David Feith3, Jeffrey Ledbetter2, Gordon Starkebaum1, Thomas Loughran Jr.4 and Keith B. Elkon1, 1Department of Medicine, Division of Rheumatology, University of Washington, Seattle, WA, 2University of Washington, Seattle, WA, 3Hematology and Oncology, University of Virginia, Charlottesville, VA, 4Hematology Oncology, University of Virginia, Charlottesville, VA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: citrullination, neutropenia and rheumatoid arthritis, pathogenesis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

BACKGROUND/PURPOSE:

Protein citrullination, the post-translational conversion of arginine to citrulline, mediated by peptidylarginine deiminase (PAD) enzymes, is considered a likely mechanism for the stimulation of anti-citrullinated protein antibodies (ACPA) in patients with rheumatoid arthritis (RA). Hypercitrullination, the citrullination of multiple intracellular proteins, was recently demonstrated in synovial fluid (SF) cells from RA patients (Romero et al.Sci Transl Med, 2013). This unique form of citrullination is proposed to occur via immune-mediated, pore-forming membranolytic pathways such as perforin-granzyme activation, but is not found in other physiological processes involving citrullination, such as NETosis. Indeed, recent findings demonstrate perforin and granzyme-producing CD8+T effector cells in the synovium of pre-clinical RA patients as well as in the peripheral blood (PB) and SF of active RA patients, and persisting into disease remission.

Insight into the existence of potential cytotoxic mechanisms occurring in RA comes from the co-occurrence of RA in up to 36% of cases of T-cell Large Granular Lymphocyte (T-LGL) Leukemia, a clonal condition characterized by severe neutropenia attributed to the killing of neutrophils or their precursors by cytotoxic CD8+ T cells. Interestingly, CD8+T cells with features of LGLs were found in the SF of RA patients without LGL leukemia, but not in the SF of psoriatic arthritis and ankylosing spondylitis patients. We thus decided to test LGL leukemia as a model for neutrophil-directed cytotoxicity contributing to hypercitrullination and disease propagation in inflamed joints of ACPA+ RA patients.

METHODS:

The sera of 11 T-LGL leukemia patients (T-LGL-RA) and 15 T-LGL leukemia patients with co-existing RA (T-LGL+RA) with absolute neutrophil count (ANC) < 500 were analyzed for ACPA positivity by ELISA. ACPA titers and ANC of each group of patients were compared using unpaired two-tailed T tests. Hypercitrullination in PB neutrophils was analyzed by immunoblotting electrophoresed neutrophil cell lysates using a broad-spectrum anti-citrulline antibody. Ionomycin was used as a positive control for hypercitrullination.

RESULTS:

All T-LGL+RA were ACPA positive, in stark contrast to the T-LGL patients without co-existing RA (Fig. 1A). Of interest, T-LGL+RA patients had decreased ANC (Fig. 1B) as compared to T-LGL-RA patients, supporting the hypothesis of neutrophil destruction in development of ACPA positivity. Importantly, hypercitrullination was observed in neutrophils isolated from both RA and T-LGL+RA patients.

CONCLUSION:

These results are consistent with the hypothesis that in T-LGL+RA, ACPA generation may result from neutrophil-directed lysis and hypercitrullination. Elucidating the cause of neutrophil-directed cytotoxicity may help to uncover a mechanism for hypercitrullination, ACPA formation and RA disease propagation.


Disclosure: T. Gazitt, None; C. Lood, None; X. Sun, None; D. Feith, None; J. Ledbetter, None; G. Starkebaum, None; T. Loughran Jr., None; K. B. Elkon, Resolve Therapeutics, LLC, 4.

To cite this abstract in AMA style:

Gazitt T, Lood C, Sun X, Feith D, Ledbetter J, Starkebaum G, Loughran T Jr., Elkon KB. Cell-Mediated Neutrophil Lysis-a Mechanism Promoting Hypercitrullination in Rheumatoid Arthritis? [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/cell-mediated-neutrophil-lysis-a-mechanism-promoting-hypercitrullination-in-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cell-mediated-neutrophil-lysis-a-mechanism-promoting-hypercitrullination-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology